ImmuPharma plc (LON:IMM – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.24 and traded as low as GBX 6.50. ImmuPharma shares last traded at GBX 6.50, with a volume of 837,072 shares.
ImmuPharma Trading Down 2.1%
The stock has a fifty day simple moving average of GBX 7.15 and a 200-day simple moving average of GBX 8.27. The stock has a market cap of £32.68 million, a price-to-earnings ratio of -7.30 and a beta of 3.02.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
